09.11.2017 • TopicsAfricaImperialpharmaceutical logistics

Challenges for Pharmaceutical Logistics in South Africa

Dr. Iain Barton, Executive Healthcare, Imperial Logistics Group, South Africa
Dr. Iain Barton, Executive Healthcare, Imperial Logistics Group, South Africa

In a worldwide comparison Africa is currently a very small and economically sub-scale and micro-fragmented market. It accounts for just two percent of the global pharmaceutical market, and when South Africa is excluded, has approximately half a percent of the global market spread across about 40 different countries in Sub-Saharan Africa. In Africa, there is a constant shortage of skilled workers and supply chain infrastructure. Storage capacity and quality storage facilities are scarce. Building a new pharmaceutical warehouse poses its own challenges, as engineering specs and limited oversight may result in defects like concrete that crumbles under the wheels of a forklift. With the exception of South Africa, most African countries also have poor road infrastructure, fragmented airline routes and insufficient flight connections for airfreight, which compromises pharmaceutical logistics.

Security risks prevalent in Africa’s pharmaceutical supply chain include not just theft, but also sub-standard counterfeit products that can jeopardize the reputation of established brands. One of the biggest obstacles hampering healthcare delivery in Africa is the lack of harmony in drug regulations across the continent. Since each country has different regulations, product registration becomes extremely complex and costly. As a result, many drug companies are not registering medicines in African countries.

As Africa’s leading partner in the healthcare supply chain, Imperial has taken up the continent’s challenges, and offers holistic supply chain solutions to deliver essential medicines to those in need. For multinational pharmaceutical manufacturers, Imperial’s solutions mitigate the risks and complexity of doing business in Africa. With multiple clients benefiting from its established, proven network, infrastructure, people, systems and continuous improvement initiatives, Imperial creates scale and reduces the risks for global companies in African markets.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.